Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: Involvement of mitochondria-regulated apoptosis

Experimental and Toxicologic Pathology

Volumn 62, Issue 5, 2010, Pages 461-469

  Abdelwahab, Siddig Ibrahim ^a   Abdul, Ahmad Bustamam ^a   Devi, Nirmala ^a   Ehassan Taha, Manal Mohamed ^a   Al zubairi, Adel Sharaf ^a   Mohan, Syam ^a   Mariod, Abdelbasit Adam ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Apoptosis; Bax protein; Cervical intraepithelial neoplasia; Cisplatin; TUNEL assay; Zerumbone

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DIETHYLSTILBESTROL; PROTEIN BAX; PROTEIN BCL 2; RNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ZERUMBONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER REGRESSION; CANCER TISSUE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; MITOCHONDRION; MOUSE; NICK END LABELING; NONHUMAN; PRENATAL EXPOSURE; PROGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU;

MUS;

EID: 77954426332     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.06.005     Document Type: Article

References (35)

1. Abdul B.A., Adel S., Nirmala D.T., Siddig I.A., Zain Z., Sharin R., et al. Anticancer activity of natural compound (zerumbone) extracted from Zingiber zerumbet in human HeLa cervical cancer cells. Int J Pharmacol 2008, 4:160-168.
2. Abdul A.B., Siddig I., Nirmala D., Muhamed N.H., Adel S.A., Syam M.M. The establishment and use of an in vivo animal model for cervical intra-epithelial neoplasia (CIN). Int J Cancer Res 2008, 4(3):61-70.
3. Abdelwahab SI, Abdul AB, Alzubairi AS, Elhassan MM, Syam MM. In vitro ultra-morphological assessment of apoptosis induced by zerumbone on human cervical cancer cells (HeLa). Journal of Biomedicine and Biotechnology 2009, Article ID 769568, 10 pp.
4. Araldi E.M., Dell'aica I., Sogno I., Lorusso G., Garbisa S., Albini A. Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer. Curr Cancer Drug Targets 2008, 8:146-155.
5. Bhalla K.N. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003, 8;22:9075-9086.
6. Branca M., Ciotti M., Giorgi C., Santini D., Di Bonito L., Costa S., et al. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol 2007, 130:223-231.
7. Campàs C., Cosialls A.M., Barragán M., Iglesias-Serret D., Santidrián A.F., Coll-Mulet L., et al. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp Hematol 2006, 34:1663-1669.
8. Chandra Mohan K.V., Devaraj H., Prathiba D., Hara Y., Nagini S. Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis. Biochim Biophys Acta 2006, 1760:1536-1544.
9. Chiarugi V., Magnelli L., Cinelli M. Complex interplay among apoptosis factors: RB, P53, E2F, TGF-b, cell cycle inhibitors and the Bcl2 gene family. Pharmacol Res 1997, 35:257-261.
10. Chiena T.Y., Chenb L.G., Leea C.J., Leec F.Y., Wanga C.C. Anti-inflammatory constituents of Zingiber zerumbet. Food Chem 2008, 110:584-589.
11. Daniela S., Marcel H., Vladimir K., Józefa W. Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin. Cancer Detect Prev 2003, 27:481-493.
12. Fadare O., Rodriguez R. Squamous dysplasia of the uterine cervix: tissue sampling-related diagnostic considerations in 600 consecutive biopsies. Int J Gynecol Pathol 2007, 26:469-474.
13. Fend F., Emmert-Buck M.R., Chuaqui R., Cole K., Lee J., Liotta L.A., et al. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 1999, 154:61-66.
14. Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25:4798-4811.
15. Hamann M.T. Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysis. Curr Pharm Des 2003, 9:879-889.
16. Iguchi T., Watanabe H., Ohta Y., Blumberg B. Developmental effects: oestrogen-induced vaginal changes and organotin-induced adipogenesis. Int J Androl 2008, 31:263-268.
17. Jin-Rui D., John H C., James M., Michael R. Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z. zerumbet. Nat Prod Res 1997, 10:115-118.
18. Kirana C., McIntosh G.H., Record I.R., Jones G.P. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer 2003, 45:218-225.
19. Liu X., Yue P., Zhou Z., Khuri F.R., Sun S.Y. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004, 96:1769-1780.
20. Meropol N.J., Schulman K.A. Cost of cancer care: issues and implications. J Clin Oncol 2007, 10:180-186.
21. Murakami A., Hayashi R., Tanaka T., Kwon K.H., Ohigashi H., Safitri R. Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination. Biochem Pharmacol 2003, 66:1253-1261.
22. Murakami A., Miyamoto M., Ohigashi H. Zerumbone, an anti-inflammatory phytochemical, induces expression of proinflammatory cytokine genes in human colon adenocarcinoma cell lines. Biofactors 2004, 21:95-101.
23. Nakamura Y., Yoshida C., Murakami A., Ohigashi H., Osawa T., Uchida K. Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett 2004, 572:245-250.
24. Nobuji N., Akiko J., Toshiya M., Shigetomo Y. Flavonoid constituents of Zingiber zerumbet Smith. Agri Biol Chem 1991, 55:455-460.
25. Patel V., Hood B.L., Molinolo A.A., Lee N.H., Conrads T.P., Braisted J.C., et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 2008, 15:1002-1014.
26. Sakinah S.A., Handayani S.T., Hawariah L.P. Zerumbone induced apoptosis in liver caner cells via modulation of Bax/Bcl-2 ratio. Cancer Cell Int 2007, 7:4.
27. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007, 57:7-28.
28. Sugiyama Y., Sugiyama K., Hirai Y., Akiyama F., Hasumi K. Microdissection isessential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol 2002, 117:109-116.
29. Tanaka T., Shimizu M., Kohno H., Yoshitani S., Tsukio Y., Murakami A., et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci 2001, 69:1935-1945.
30. Titus-Ernstoff L., Troisi R., Hatch E.E., Hyer M., Wise L.A., Palmer J.R., et al. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology 2008, 19:251-257.
31. Twyman R.M., Schillberg S., Fischer R. Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 2005, 10(1):185-218.
32. Vogel V.G. Ontology, oncology, and preventive economies: developing drugs for cancer prevention. Clin Cancer Res 2007, 15:5488-5496.
33. Waalkes M.P., Liu J., Ward J.M., Powell D.A., Diwan B.A. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res 2006, 66:1337-1345.
34. Yin Q., Brody A.R., Sullivan D.E. Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure. Int J Exp Pathol 2007, 88:415-425.
35. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome C-dependent activation of caspase-3. Cell 1997, 90:405-413.